SCHEMBL2528684

SCHEMBL2528684

CN(CC(O)c1ccc(OS(=O)(=O)c2cc(C(F)(F)F)ccc2Cl)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.37
RXRA P19793 2/20 0.36
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CACNA1G O43497 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNA1C Q13936 1/20 0.33
ENPP3 O14638 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2529298 0.93 FFAR1 (0.34) RXRANR1H2NR1H3MAPTKDM4E
SCHEMBL2528064 0.89 ALDH1A1 (0.39) MAPTMEN1KMT2AGAAALDH1A1
SCHEMBL2532582 0.88 MEN1 (0.36) MEN1KMT2ACACNA1GCACNA1BCACNA1C
SCHEMBL2527589 0.85 ENPP3 (0.44) HSD11B1MAPTKDM4EMEN1KMT2A
SCHEMBL2530277 0.85 ALPL (0.38) MAPTMEN1KMT2AALDH1A1F2R
SCHEMBL2528896 0.85 PSEN1 (0.42) HSD11B1CACNA1GCACNA1BCACNA1CENPP3
SCHEMBL2528541 0.84 MEN1 (0.37) MEN1KMT2A
SCHEMBL2526645 0.84 CCR2 (0.38) L3MBTL1
SCHEMBL2525351 0.84 GAA (0.39) HSD11B1MAPTKDM4EMEN1KMT2A
SCHEMBL2526409 0.83 AOC3 (0.34) MEN1KMT2AALDH1A1F2RHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039501-B2 Synephrine derivatives useful as anti-inflammatory agents UNIVERSITEIT GENT (BE) 2011-10-18 US disclosed
US-20090029999-A1 Synephrine derivatives useful as anti-inflammatory agents UNIVERSITEIT GENT (BE) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029999-A1 Synephrine derivatives useful as anti-inflammatory agents HRH1, HRH3, HRH2 HSD11B1 2306/4885RXRA 2135/4885NR1H2 555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.